Sleep duration and ischemic heart disease and all-cause mortality: Prospective cohort study on effects of tranquilizers/hypnotics and perceived stress

Scandinavian Journal of Work, Environment and Health

Volumn 39, Issue 6, 2013, Pages 550-558

  Garde, Anne Helene ^a   Hansen, Åse Marie ^a,b   Holtermann, Andreas ^a   Gyntelberg, Finn ^c   Suadicani, Poul ^c  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Copenhagen Male Study; Male

Indexed keywords

HYPNOTIC AGENT; TRANQUILIZER;

BASELINE SURVEY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE INCIDENCE; ENVIRONMENTAL STRESS; MENS HEALTH; MORTALITY; PERCEPTION; PSYCHOLOGY; RISK FACTOR; SLEEP; WORKPLACE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FITNESS; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JOB STRESS; LEISURE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP TIME; SMOKING; SOCIAL CLASS; SYSTOLIC BLOOD PRESSURE;

DENMARK; HOVEDSTADEN; KOBENHAVN [(RGG) HOVEDSTADEN];

ADULT; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; SLEEP; STRESS, PSYCHOLOGICAL; TRANQUILIZING AGENTS;

EID: 84887122481     PISSN: 03553140     EISSN: 1795990X     Source Type: Journal    
DOI: 10.5271/sjweh.3372     Document Type: Article

References (43)

1. Amagai Y, Ishikawa S, Gotoh T, Doi Y, Kayaba K, Nakamura Y, et al. Sleep duration and mortality in Japan: the Jichi Medical School Cohort Study. J Epidemiol. 2004;14:124-8. http://dx.doi.org/10.2188/jea.14.124.
2. Lan TY, Lan TH, Wen CP, Lin YH, Chuang YL. Nighttime sleep, chinese after-noon nap, and mortality in the elderly. Sleep. 2007;30:1105-10.
3. Ferrie JE, Shipley MJ, Cappuccio FP, Brunner E, Miller MA, Kumari M, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep. 2007;30:1659-66.
4. Ikehara S, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, et al. Association of Sleep Duration with Mortality from Cardiovascular Disease and Other Causes for Japanese Men and Women: the JACC Study. Sleep. 2009;32:29-301.
5. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, et al. A prospective study of sleep duration and mortality risk in women. Sleep. 2004;27:440-4.
6. Burazeri G, Gofin J, Kark JD. Over 8 hours of sleep--marker of increased mor-tality in Mediterranean population: follow-up population study. Croat Med J. 2003;44:193-8.
7. Heslop P, Smith GD, Metcalfe C, Macleod J, Hart C. Sleep duration and mortali-ty: The effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med. 2002;3:305-14. http://dx.doi.org/10.1016/S1389-9457(02)00016-3.
8. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59:131-6. http://dx.doi.org/10.1001/archpsyc.59.2.131.
9. Kripke DF, Langer RD, Elliott JA, Klauber MR, Rex KM. Mortality related to acti-graphic long and short sleep. Sleep Med. 2011;12:28-33. http://dx.doi.org/10.1016/j.sleep.2010.04.016.
10. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Opler MG, et al. Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep. 2008;31:1087-96.
11. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009;18:148-58. http://dx.doi.org/10.1111/j.1365-2869.2008.00732.x.
12. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33:585-92.
13. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration pre-dicts cardiovascular outcomes: a systematic review and meta-analysis of pro-spective studies. Eur Heart J. 2011;32:1484-92. http://dx.doi.org/10.1093/eurheartj/ehr007.
14. Suzuki E, Yorifuji T, Ueshima K, Takao S, Sugiyama M, Ohta T, et al. Sleep duration, sleep quality and cardiovascular disease mortality among the elderly: a population-based cohort study. Prev Med. 2009;49:135-41. http://dx.doi.org/10.1016/j.ypmed.2009.06.016.
15. Shankar A, Koh WP, Yuan JM, Lee HP, Yu MC. Sleep Duration and Coronary Heart Disease Mortality Among Chinese Adults in Singapore: A Population-based Cohort Study. Am J Epidemiol. 2008;168:1367-73. http://dx.doi.org/10.1093/aje/kwn281.
16. Wingard DL, Berkman LF. Mortality risk associated with sleeping patterns among adults. Sleep. 1983;6:102-7.
17. Kronholm E, Laatikainen T, Peltonen M, Sippola R, Partonen T. Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med. 2011;12:215-21. http://dx.doi.org/10.1016/j.sleep.2010.07.021.
18. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Ef-fect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascu-lar risk. J Am Coll Cardiol. 2004;43:678-83. http://dx.doi.org/10.1016/j.jacc.2003.07.050.
19. Spiegel K, Leproult R, van Cauter E. Impact of sleep debt on metabolic and en-docrine function. Lancet. 1999;354:1435-9. http://dx.doi.org/10.1016/S0140-6736(99)01376-8.
20. Eller NH, Netterstrom B, Gyntelberg F, Kristensen TS, Nielsen F, Steptoe A, et al. Work-related psychosocial factors and the development of ischemic heart disease: a systematic review. Cardiol Rev. 2009;17:83-97. http://dx.doi.org/10.1097/CRD.0b013e318198c8e9.
21. Backe EM, Seidler A, Latza U, Rossnagel K, Schumann B. The role of psycho-social stress at work for the development of cardiovascular diseases: a system-atic review. Int Arch Occup Environ Health. 2012;85:67-79. http://dx.doi.org/10.1007/s00420-011-0643-6.
22. Andersen I, Diderichsen F, Kornerup H, Prescott E, Rod NH. Major life events and the risk of ischaemic heart disease: does accumulation increase the risk? Int J Epidemiol. 2011;40:904-13. http://dx.doi.org/10.1093/ije/dyr052.
23. Geurts SA, Sonnentag S. Recovery as an explanatory mechanism in the rela-tion between acute stress reactions and chronic health impairment. Scand J Work Environ Health. 2006;32:482-92. http://dx.doi.org/10.5271/sjweh.1053.
24. Meijman TF, Mulder G. Psychological aspects of workload. In: Drenth PJD, Thierry H, de Wolff CJ, editors. Handbook of work and organizational psychology. 2nd ed. Hove: Psychology Press; 1998. p. 5-33.
25. McEwen BS. Stress, Adaptation, and Disease: Allostasis And Allostatic Load. Ann N Y Acad Sci. 1998;33-44. http://dx.doi.org/10.1111/j.1749-6632.1998.tb09546.x.
26. Sterling P, Eyer J. Allostasis: A New Paradigm to Explain Arousal Pathology. In: Fisher S, Reason J, editors. Handbook of Life Stress, Cognition and Health. Chichester: John Wiley & Sons; 1988. p. 629-49.
27. Ursin H, Eriksen HR. The cognitive activation theory of stress. Psychoneuroen-docrinology. 2004;29:567-92. http://dx.doi.org/10.1016/S0306-4530(03)00091-X.
28. Gyntelberg F. Original title [Physical fitness and coronary heart-disease male residents in Copenhagen aged 40-59]. Dan Med Bull 1973;20:1-4.
29. Gyntelberg F. Original title [One-year and 2-years incidence of myocardial-infarction in Copenhagen males aged 40-59]. Dan Med Bull 1975;22:81-4.
30. Hein HO, Suadicani P, Gyntelberg F. Ischaemic heart disease incidence by so-cial class and form of smoking: the Copenhagen Male Study--17 years' follow-up. J Intern Med. 1992;231:477-83. http://dx.doi.org/10.1111/j.1365-2796.1992.tb00963.x.
31. Åstrand P-O, Rodahl K. Textbook of work physiology. Physiological bases of exercise. New York: McGraw-Hill Book Company; 1986.
32. Svalastoga K. Prestige, class and mobility. Copenhagen: Munksgaard; 1959.
33. Hansen EJ. Original title [Socialgrupper i Danmark]. Copenhagen: Socialforskningsinstituttet; 1984.
34. Knutson KL, Rathouz PJ, Yan LL, Liu K, Lauderdale DS. Intra-individual daily and yearly variability in actigraphically recorded sleep measures: the CARDIA study. Sleep. 2007;30:793-6.
35. Åkerstedt T. Psychosocial stress and impaired sleep. Scand J Work Environ Health. 2006;32:493-501. http://dx.doi.org/10.5271/sjweh.1054.
36. Ohayon MM. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med. 2005;165:35-41. http://dx.doi.org/10.1001/archinte.165.1.35.
37. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open. 2012;2:e000850. http://dx.doi.org/10.1136/bmjopen-2012-000850.
38. Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish popula-tion. J Intern Med. 2002;251:207-16. http://dx.doi.org/10.1046/j.1365-2796.2002.00941.x.
39. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open. 2012;2:e000850. http://dx.doi.org/10.1136/bmjopen-2012-000850.
40. Madsen M, Balling H, Eriksen LS. Original title [The validity of the diagnosis of acute myo-cardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry]. Dan Med Bull. 1990;152:308-14.
41. Mosbech J, Jorgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. Original title [The national patient registry. Evaluation of data quality]. Dan Med Bull. 1995;157:3741-5.
42. Joldal B, Halvorsen I. Sales statistics in the control of drug abuse in Norway. Bull Narc. 1982;34:57-68.
43. Mendelson WB. Hypnotic Medications: Mechanisms of action and pharmacologic effects. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4 ed. Philadelphia: Elsevier Saunders; 2005. p. 444-51.